Abstract
We present an unusual case of a patient with an intracranial low-grade oligodendroglioma
who developed recurrence with an intramedullary spinal cord metastasis and multiple
spinal leptomeningeal metastases. The intramedullary spinal cord metastasis showed
mild enhancement similar to the original intracranial primary, while the multiple
spinal leptomeningeal metastases revealed no enhancement. This is the seventh reported
case of symptomatic intramedullary spinal cord metastasis from a low-grade oligodendroglioma.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Leptomeningeal metastases.Neurol Clin. 2003; 21: 25-66
- Intramedullary spinal cord metastasis. A clinicopathological study of 13 cases.J Neurosurg. 1985; 62: 227-233
- Meningeal gliomatosis: a review of 12 cases.Ann Neurol. 1980; 8: 605-608
- Extra primary seeding of glioblastoma multiforme in the subarachnoid space and ependyma.Neurology. 1963; 13: 855-865
- Systematic review of primary intracranial glioblastoma multiforme with symptomatic spinal metastases, with two illustrative patients.J Clin Neurosci. 2012; 19: 1080-1086
- Current diagnosis and treatment of oligodendroglioma.Neurosurg Focus. 2002; 12: E2
- Symptomatic spinal cord metastasis from cerebral oligodendroglioma.Neurol Sci. 2012; 33: 609-613
- Intramedullary spread of a cerebral oligodendroglioma. Two case reports.Neuro-Chirurgie. 2000; 46: 558-562
- Intramedullary spinal cord metastases: clinical features and treatment outcome.Neurology. 1996; 47: 906-912
- Metastatic oligodendrogliomas: a review of the literature and case report.Acta Neurochir (Wien). 2008; 150 ([discussion 702–693]): 699-702
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas.Neurology. 2010; 75: 1560-1566
Article info
Publication history
Published online: March 10, 2014
Accepted:
February 25,
2014
Received in revised form:
February 13,
2014
Received:
November 27,
2013
Footnotes
☆Funding source: none.
☆☆Conflict of interest: none.
★Disclosure: none.
Identification
Copyright
© 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
